Pfizer/BioNTech to Seek Emergency Vaccine Approval in US Friday

Pfizer/BioNTech to Seek Emergency Vaccine Approval in US Friday

#Pfizer #OperationWarpSpeed #government #COVID #vaccine $PFE UpDate: An emergency use authorization request for the COVID-19 vaccine developed by Pfizer and BioNTech was expected to be filed with the FDA on Friday, the US government and BioNTech’s co-founder said. This type of Food and Drug Administration authorization is temporary or conditional and is granted in response […]

COVID is Over, President Trump’s Policy Defeated It as Promised

COVID is Over, President Trump’s Policy Defeated It as Promised

#COVID #vaccine $PFE The Pfizer/BioNTech COVID-19 vaccine will “bash the virus over the head” and end the spiraling pandemic, the scientist behind the companies’ breakthrough declared.  “If the question is whether we can stop this pandemic with this vaccine, then my answer is: yes because I believe that even protection only from symptomatic infections will […]

Pfizer Vs President Trump’s ‘Operation Warp Speed’

Pfizer Vs President Trump’s ‘Operation Warp Speed’

#PresidentTrump #Pfizer #COVID #vaccine $PFE Pfizer (NYSE:PFE) of the drug makers racing to develop a COVID vaccine, on Tuesday backtracked after distancing itself from President Trump’s Operation Warp Speed. Monday, Pfizer said an early analysis of its trial suggested the vaccine was robustly effective in preventing the coronavirus. The announcement was followed by Tweets from […]

The COVID Vaccine Breakthrough News Brought in $2-Trillion in Trade

The COVID Vaccine Breakthrough News Brought in $2-Trillion in Trade

#COVID #vaccine #trade #stocks #bonds $DIA $SPY $QQQ $RUTX $PFE $JPY $VXX “Turnover was about 3X the 30-day average daily volumes in cash and very active in the futures space“– Paul Ebeling News of a breakthrough in the race to find a COVID vaccine triggered 1 of the heaviest trading days since the height of […]

Pfizer and Array BioPharma Merger Agreement

Pfizer and Array BioPharma Merger Agreement

Pfizer Inc (NYSE: PFE) and Array BioPharma Inc. (NASDAQ: ARRY) today announced that they have entered into a definitive merger agreement. Under which Pfizer will acquire Array. Array is a commercial stage biopharmaceutical company. They focus on the discovery, development and commercialization of targeted small molecule medicines to treat cancer and other diseases of high unmet need. […]

Pfizer (NYSE:PFE) Expected Target 34.88

Pfizer (NYSE:PFE) Expected Target 34.88

Pfizer (NYSE:PFE) Expected Target 34.88 Overall, the bias in prices is: Downwards. Short term: Prices are stalling. Intermediate term: Prices are trending. By the way, prices are vulnerable to a correction towards 34.88. The projected upper bound is: 34.54. The projected lower bound is: 32.46. The projected closing price is: 33.50. Candlesticks A black body […]